Concepedia

Author

Efrat Flashner-Abramson

Hebrew University of Jerusalem

Also Known As

E Flashner-Abramson, E. Flashner-Abramson, Efrat Flashner-Abramson, Flashner-Abramson, Efrat

55

Publications

506

Citations

11

H-Index

13

Concepts

All Affiliations

Hebrew University of JerusalemThe University of Texas MD Anderson Cancer CenterHadassah Medical Center
EF

About

Efrat Flashner-Abramson is an author at Hebrew University of Jerusalem specializing in medicine, cell signaling, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

212

2

Cell Biology

2

2

201

3

Immunology

2

2

201

4

Molecular Biology

1

1

11

5

Structural Biology

1

1

11

Efrat Flashner-Abramson

×

11

Publications

488

Citations

11

H-Index

YearCitations

Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling

Elsa Sánchez‐López, Efrat Flashner-Abramson, Shabnam Shalapour,

Oncogene

2015

159

Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment

Hadas Reuveni, Efrat Flashner-Abramson, Lilach Steiner,

Cancer Research

2013

122

Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling

Efrat Flashner-Abramson, Shiri Klein, Gerard E. Mullin,

Oncogene

2015

42

Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy

Efrat Flashner-Abramson, Swetha Vasudevan, Ibukun Adesoji Adejumobi,

Theranostics

2019

40

Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations

Swetha Vasudevan, Efrat Flashner-Abramson, Heba Alkhatib,

npj Precision Oncology

2021

26

Personalized disease signatures through information-theoretic compaction of big cancer data

Swetha Vasudevan, Efrat Flashner-Abramson, F. Remacle,

Proceedings of the National Academy of Sciences

2018

22

Impact of the Anticancer Drug NT157 on Tyrosine Kinase Signaling Networks

Shih‐Ping Su, Efrat Flashner-Abramson, Shoshana Klein,

Molecular Cancer Therapeutics

2018

19

Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes

Maria R. Jubran, Daniela Vilenski, Efrat Flashner-Abramson,

Theranostics

2022

19

Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance

Heba Alkhatib, Ariel M. Rubinstein, Swetha Vasudevan,

Genome Medicine

2022

17

PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice

Yael Langut, Alaa Talhami, Mamidi Samarasimhareddy,

Proceedings of the National Academy of Sciences

2017

11

Page 1